These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 24123923)

  • 1. Viral clearance capability of monoclonal antibody purification.
    Cai K; Anderson J; Utiger E; Ferreira G
    Biologicals; 2024 Feb; 85():101751. PubMed ID: 38387156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pH, NaCl concentration, and mAb concentration of feed solution on the filterability of Planova™ 20N and Planova™ BioEX.
    Hashikawa-Muto C; Yokoyama Y; Hamamoto R; Kobayashi K; Masuda Y; Nonaka K
    Biotechnol Prog; 2024; 40(2):e3420. PubMed ID: 38146091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus filtration using small pore virus filter in downstream processing of biotherapeutic products: The effect of operating pressure.
    Liu N; Xu T
    Biologicals; 2023 Nov; 84():101718. PubMed ID: 37837714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of small-scale models to understand the impact of continuous downstream bioprocessing on integrated virus filtration.
    Lute S; Kozaili J; Johnson S; Kobayashi K; Strauss D
    Biotechnol Prog; 2020 May; 36(3):e2962. PubMed ID: 31945257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellulose-based virus-retentive filters: a review.
    Junter GA; Lebrun L
    Rev Environ Sci Biotechnol; 2017; 16(3):455-489. PubMed ID: 32214924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of proteins and protein fouling on virus retention during virus removal filtration.
    Afzal MA; Zydney AL
    Biotechnol Bioeng; 2024 Feb; 121(2):710-718. PubMed ID: 37994529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapting virus filtration to continuous processing: Effects of product and process variability on filtration performance.
    Kozaili J; Rayfield W; Gospodarek A; Brower M; Strauss D
    Biotechnol Prog; 2024; 40(2):e3407. PubMed ID: 38146086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of biomanufacturing processes from virus contamination through upstream virus filtration of cell culture media.
    Wieser A; Modrof J; Kreil TR
    Biotechnol Bioeng; 2023 Oct; 120(10):2917-2924. PubMed ID: 37337932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial virus filtration: A case study evaluating the product-dependent impact of control strategies on process efficiency.
    Kozaili J; Shah A; Robbins D; Brinkman N; Burdick M; Strauss D
    Biotechnol J; 2023 Sep; 18(9):e2200599. PubMed ID: 37218550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of Dry and Wet Porometry Methods for Characterization of Regular and Cross-Linked Virus Removal Filter Papers.
    Gustafsson S; Westermann F; Hanrieder T; Jung L; Ruppach H; Mihranyan A
    Membranes (Basel); 2018 Dec; 9(1):. PubMed ID: 30577520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of viruses using novel protein A wash buffers.
    Bolton GR; Selvitelli KR; Iliescu I; Cecchini DJ
    Biotechnol Prog; 2015; 31(2):406-13. PubMed ID: 25482293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of the rodent retrovirus, XMuLV, by protein A chromatography.
    Bach J; Connell-Crowley L
    Biotechnol Bioeng; 2015 Apr; 112(4):743-50. PubMed ID: 25335906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of indicator microorganisms and biological hazards by standard and/or alternative processing methods in Category 2 and 3 animal by-products and derived products to be used as organic fertilisers and/or soil improvers.
    ; Koutsoumanis K; Allende A; Bolton D; Bover-Cid S; Chemaly M; Davies R; De Cesare A; Herman L; Hilbert F; Lindqvist R; Nauta M; Peixe L; Ru G; Simmons M; Skandamis P; Suffredini E; Bottari B; Cummins E; Ylivainio K; Muñoz Guajardo I; Ortiz-Pelaez A; Alvarez-Ordóñez A
    EFSA J; 2021 Dec; 19(12):e06932. PubMed ID: 34900004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing therapeutic monoclonal antibodies at pandemic pace.
    Kelley B
    Nat Biotechnol; 2020 May; 38(5):540-545. PubMed ID: 32317764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to achieving modular retrovirus clearance for a parvovirus filter.
    Stuckey J; Strauss D; Venkiteshwaran A; Gao J; Luo W; Quertinmont M; O'Donnell S; Chen D
    Biotechnol Prog; 2014; 30(1):79-85. PubMed ID: 24123923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of Planova filters in manufacturing processes of biologicals improve the virus safety effectively: A review of publicly available data.
    Gröner A
    Biotechnol Prog; 2024; 40(1):e3398. PubMed ID: 37985214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic evaluation of virus clearance by depth filtration.
    Venkiteshwaran A; Fogle J; Patnaik P; Kowle R; Chen D
    Biotechnol Prog; 2015; 31(2):431-7. PubMed ID: 25683459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
    Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
    Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.